News
Through tireless work and reinvesting profits back into our company, we developed new products and earned recognition and praise from the industry. As we look to the future, we aim to continue pushing the boundaries of innovation and excellence in our industry, with the ultimate goal of making a positive impact on the health and wellbeing of people everywhere.
You are here: Home / News
67cabd8f-8740-40b2-a456-8086f9bd07a1.png
Clinical Applications of Anti-Müllerian Hormone (AMH)

AMH serves as a powerful, stable marker of female reproductive health — from assessing fertility potential and guiding assisted reproduction, to detecting ovarian disorders. Regular monitoring of AMH not only empowers women with insight into their fertility timeline but also enables early, informed decisions about reproductive planning. At Medlere, we are dedicated to supporting reproductive and endocrine health through advanced diagnostic innovation. Both our FiCA Immunofluorescence Analyzer and UClia POCT CLIA Analyzer provide reliable and accurate AMH testing solutions, offering clinicians versatile options for routine and point-of-care testing environments.

READ MORE
10/ 15 / 2025
Hormonal Imbalance Fundraising and Donation Women's Health Instagram Post in Peach Dark Brown Corporate Friendly Style.png
Hormone Testing for Women: Understanding and Managing Women's Health

Hormones are substances that send chemical messages in the body and have a variety of effects on processes like physical development, reproduction, and mood. People of any sex have a wide range of hormones in their body. Hormone testing for women and people assigned female at birth often focuses on hormones that play a role in puberty, fertility, menopause, and health conditions more common in this population. Hormone tests for women can be used to confirm pregnancy, track menopause, detect hormonal imbalances, and understand the cause of reproductive health issues.

READ MORE
04/ 29 / 2024
flu.png
Rapid Diagnostic Test for Respiratory Infections

With the onset of winter, there is an increase in acute respiratory infections caused by various respiratory pathogens recently. As in other infectious processes, swift accurate diagnosis is associated with more targeted and effective treatment, lower transmission of the disease and, often, a reduction in its duration. To combat rise of acute respiratory infections, Medlere provides rapid quantitative tests for respiratory infections basing on immunofluorescence technology, which delivers rapid and accurate results within minutes. • RSV (Respiratory Syncytial Virus) • ADV (Adenovirus) • Influenza A/B • SARS-CoV-2 • SARS-CoV-2/InfluenzaA/B • Mycoplasmsa Pneumoniae

READ MORE
12/ 01 / 2023
微信图片_20231102160426.png
The Crucial Role of Immunofluorescence Assay in the IVD Industry

Medlere's Fluorescence Immunoassay sets a new standard for Point-of-Care Testing (POCT) solutions. This system delivers rapid and accurate results within minutes. Designed with user-friendliness in mind, our Fluorescence Immunoassay empowers healthcare professionals with a reliable tool to diagnose a wide range of diseases and conditions, elevating patient care and treatment outcomes.

READ MORE
03/ 28 / 2022

Who We Are

With the ultimate goal of making a positive impact on the health and wellbeing of people everywhere.
Contact Us
Address: 291 Brighton Road South Croydon United Kingdom Cr2 6Eq    E-mail: info@medlere.com    Tel.: +447565748991
The content on the Medlere website may showcase some of our forthcoming care offerings, which are currently under development. Please note that these offerings are subject to completion of the development process and may require regulatory authorization, clearance, or approval before they can be made available for commercial use.
@​2023 Medlere Limited. All Rights Reserved.